The Global Vaccine Safety Initiative: Enhancing vaccine pharmacovigilance capacity at country level

dc.contributor.authorMaure, C.G.
dc.contributor.authorDodoo, A.N.
dc.contributor.authorBonhoefer, J.
dc.contributor.authorZuber, P.L.F.
dc.date.accessioned2018-11-23T09:04:27Z
dc.date.available2018-11-23T09:04:27Z
dc.date.issued2014-09
dc.description.abstractLarge-scale immunization programmes now extend to all parts of the world, in- cluding least developed countries, where they reach unprecedented numbers of people. e number of vaccine doses administered worldwide continues to increase as new vaccines are developed and made available, and more people have access to immunization services. Development of immunization pro- grammes in low- and middle-income countries (LMICs) has increased im- munization coverage, which in turn has led to a reduction in vaccine-preventable diseases. However, as vaccine use has increased in LMICs, so has public atten- tion to vaccine safety issues, as happened previously in high-income countries. is has created additional vulnerabil- ity for all immunization programmes. Whether or not they are well founded, concerns about serious adverse events following immunization may rapidly undermine public condence and be- come a serious threat to eective vacci- nation strategies, eroding the enormous gains in disease control achieved with decades of eort. (PDF) The Global Vaccine Safety Initiative: Enhancing vaccine pharmacovigilance capacity at country level. Available from: https://www.researchgate.net/publication/267929878_The_Global_Vaccine_Safety_Initiative_Enhancing_vaccine_pharmacovigilance_capacity_at_country_level [accessed Nov 23 2018].en_US
dc.identifier.otherDOI: 10.2471/BLT.14.138875}
dc.identifier.otherVol. 92(9): pp 695-6
dc.identifier.urihttp://ugspace.ug.edu.gh/handle/123456789/25712
dc.language.isoenen_US
dc.publisherBulletin of the World Health Organizationen_US
dc.subjectGlobal Vaccineen_US
dc.subjectpharmacovigilanceen_US
dc.subjectSafety Initiativeen_US
dc.subjectimmunizationen_US
dc.titleThe Global Vaccine Safety Initiative: Enhancing vaccine pharmacovigilance capacity at country levelen_US
dc.typeOtheren_US

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
The Global Vaccine Safety Initiative Enhancing vaccine pharmacovigilance capacity at country level.pdf
Size:
707.56 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.6 KB
Format:
Item-specific license agreed upon to submission
Description: